By inhibiting the signal transduction and kinase activity of the FAK/phosphoinositide 3 kinase (PI3K)/Akt pathway, TQ can inhibit the in vitro movement and invasion of pancreatic cancer cells in a concentration-dependent manner (Figure 4) (32). The gene discussed is AKT1; the disease is familial pancreatic carcinoma.